Table 1.
Characteristic | Total Enrolled and Tested (n = 1248) | RSV (n = 32/1248) 2.6% |
HMPV (n = 33/1248) 2.6% |
---|---|---|---|
| |||
Age (yrs), median (25%, 75%) | 51.1 (35.3, 65.5) | 60.8 (44.8, 68.9) | 61 (49.3, 67.3) |
| |||
Age group, n (%) | |||
18–49 years | 604 (48.4) | 12 (37.5) | 10 (30.3) |
≥50 years | 644 (51.6) | 20 (62.5) | 23 (69.7) |
| |||
Duration of symptoms in days, median (25%, 75%) | 3 (1, 5) | 4 (2, 6) | 3 (2, 4) |
| |||
Sex, n (%) | |||
Male | 513 (41.1) | 11 (34.4) | 10 (30.3) |
Female | 735 (58.9) | 21 (65.6) | 23 (69.7) |
| |||
Race/Ethnicity, n (%) | |||
White | 827 (66.3) | 25 (78.1) | 23 (69.7) |
Black | 386 (30.9) | 7 (21.9) | 10 (30.3) |
| |||
Living situation, n (%) | |||
Lives Alone | 231 (18.5) | 11 (34.4) | 6 (18.2) |
Lives With family | 961 (77) | 20 (62.5) | 27 (81.8) |
In nursing facility | 43 (3.5) | 1 (3.1) | 0 (0) |
| |||
Chronic illnesses, n (%) | 1013 (81.2) | 28 (87.5) | 29 (87.9) |
Cardiovascular disease | 427 (34.2) | 15 (46.9) | 14 (42.4) |
Pulmonary disease | 671 (53.8) | 22 (68.8) | 21 (63.6) |
Diabetes mellitus | 302 (24.2) | 7 (21.9) | 6 (18.2) |
Immunodeficiency* | 680 (54.5) | 19 (59.4) | 24 (72.7) |
| |||
Exposure to tobacco smoke**, n (%) | 579 (46.4) | 16 (50) | 11 (33.3) |
Abbreviations: HMPV, human metapneumovirus; IQR, interquartile range; RSV, respiratory syncytial virus.
Transplant, cancer, splenectomy, HIV/AIDS, steroid use, chemotherapy, hemoglobinopathy, immunosuppression
Smoked or had significant environmental tobacco exposure within the last 6 months